Clinical Trial Update: Acetazolamide to Prevent Impending Altitude-illness in Patients With COPD [Phase 3]

View source ↗

Summary

Phase 3 trial investigating acetazolamide to prevent impending altitude illness in patients with COPD.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Altitude Hypoxia
• Altitude Sickness
• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• ACETAZOLAMIDE (acetazolamide)

Snippet

Sponsor: University of Zurich | Conditions: Chronic Obstructive Pulmonary Disease, Altitude Sickness | Phase 3 | Status: UNKNOWN